Description:
AbbVie Inc is a prominent American biopharmaceutical firm, founded in 2013 as a spin-off from Abbott Laboratories, dedicated to the research, development, and commercialization of cutting-edge therapies across immunology, oncology, virology, and neuroscience. Renowned for its flagship immunology product, Humira, AbbVie is actively expanding its portfolio through strategic acquisitions and partnerships, enhancing its ability to tackle some of the most pressing global health challenges. With a strong commitment to innovation and a robust development pipeline, AbbVie is well-positioned to maintain its leadership in the biopharmaceutical sector and deliver substantial value to institutional investors.
Industry:
DRUG MANUFACTURERS - GENERAL
Address:
1 NORTH WAUKEGAN ROAD, NORTH CHICAGO, IL, UNITED STATES, 60064-6400
Fiscal year end:
December
Market capitalization:
$396 Billion
Dividend per share:
$6.56
How much was you spent on shares:
$1,000
How much will you earn in
10 years:
+485%
How much will you get:
$5,853
Prices dates:
31-12-2015: $39.04 and 31-12-2025: $228.49